Sandoz Group AG (SDZ.SW) Financials
SDZ.SW Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2025 | ? | ? |
| June 30, 2025 | 17.1 billion | 10.1 billion |
| Dec. 31, 2024 | 19.9 billion | 10.6 billion |
| June 30, 2024 | 19.3 billion | 9.9 billion |
SDZ.SW Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2025 | ? | ? |
| June 30, 2025 | 253.7 million | ? |
| Dec. 31, 2024 | -4.0 million | 88.0 million |
| June 30, 2024 | 64.0 million | ? |
SDZ.SW Net Income
| Date | Net Income |
|---|---|
| Dec. 31, 2025 | ? |
| June 30, 2025 | 298.9 million |
| Dec. 31, 2024 | -149.0 million |
| June 30, 2024 | 150.0 million |
SDZ.SW Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2025 | - | - | - |
| June 30, 2025 | 1.1 billion | 4.4 billion | 291.0 million |
| Dec. 31, 2024 | 1.2 billion | 4.2 billion | 302.0 million |
| June 30, 2024 | 701.0 million | 3.7 billion | 219.7 million |
SDZ.SW Shares Outstanding
SDZ.SW Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2025 | - | 437.0 million | 1.1 billion | - |
| June 30, 2025 | 161.0 million | 399.6 million | 945.1 million | - |
| Dec. 31, 2024 | 389.8 million | 300.0 million | 810.9 million | - |
| June 30, 2024 | 148.6 million | 440.3 million | 1.1 billion | - |
SDZ.SW Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2025 | 4.7 billion | 2.4 billion |
| June 30, 2025 | 4.2 billion | 2.3 billion |
| Dec. 31, 2024 | 3.7 billion | 2.1 billion |
| June 30, 2024 | 4.6 billion | 2.7 billion |
SDZ.SW
Price: CHF64.34
Dividend Yield: 1.49%
Forward Dividend Yield: 1.26%
Payout Ratio: -4500.00%
Dividend Per Share: 0.80 CHF
Earnings Per Share: 0.40 CHF
P/E Ratio: 163.60
Exchange: EBS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Switzerland
Market Capitalization: 28.7 billion
Average Dividend Frequency: 1
Years Paying Dividends: 3